Literature DB >> 20419840

Risk factors and therapeutic response in Chinese patients with peptic ulcer disease.

Shou-Wu Lee1, Chi-Sen Chang, Teng-Yu Lee, Hong-Zen Yeh, Chun-Fang Tung, Yen-Chun Peng.   

Abstract

AIM: To assess the risk factors and the efficacy of medications of patients with gastric and duodenal ulcers among Chinese patients in Taiwan.
METHODS: Patients with peptic ulcers, diagnosed by upper endoscopy, were retrospectively collected between January 2008 and December 2008. The differences were compared.
RESULTS: Among all 448 cases, 254 (56.6%) and 194 (43.4%) patients had gastric ulcers and duodenal ulcers respectively. Patients with gastric ulcers were younger than those with duodenal ulcers. Although more men existed, there was a female predominance in middle-aged cases. Patients with duodenal ulcers had a higher rate of Helicobacter pylori (H. pylori) infection (62.4% vs 43.3%, P = 0.001), and those with gastric ulcers owned a significantly higher amount of aspirin and nonsteroidal anti-inflammatory drug (NSAID) use (7.5% vs 1.5%, 6.7% vs 2.1%, P = 0.001). Tobacco smoking and alcohol drinking had no different impact between these two groups. Proton-pump inhibitors and H2-receptor antagonists (H2RA) were effective, but significantly less so in cases with duodenal ulcers receiving H2RAs, or in those with H. pylori infection and a history of NSAID use.
CONCLUSION: Patients with gastric ulcers had lower H. pylori infection but more aspirin or NSAID use. Antisecretory therapy was ineffective in gastric ulcers underwent H2RA treatment, and cases combined H. pylori infection and NSAID use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20419840      PMCID: PMC2860080          DOI: 10.3748/wjg.v16.i16.2017

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

Review 1.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

2.  Pantoprazole versus ranitidine in the treatment of duodenal ulcer: a multicenter study in Brazil.

Authors:  U G Meneghelli; S Zaterka; L de Paula Castro; O Malafaia; L G Lyra
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

3.  Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.

Authors:  Jia Qing Huang; Subbaramiah Sridhar; Richard H Hunt
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

4.  Effect of age on the frequency of active Campylobacter pylori infection diagnosed by the [13C]urea breath test in normal subjects and patients with peptic ulcer disease.

Authors:  D Y Graham; P D Klein; A R Opekun; T W Boutton
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

5.  Towards a true prevalence of peptic ulcer: the Sørreisa gastrointestinal disorder study.

Authors:  B Bernersen; R Johnsen; B Straume; P G Burhol; T G Jenssen; P A Stakkevold
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

6.  Biopsy specimen acquisition in patients with newly diagnosed peptic ulcer disease as determined from a national endoscopic database.

Authors:  Gavin C Harewood; Jennifer L Holub; David A Lieberman
Journal:  Gastrointest Endosc       Date:  2004-05       Impact factor: 9.427

Review 7.  Systematic review: the global incidence and prevalence of peptic ulcer disease.

Authors:  J J Y Sung; E J Kuipers; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2009-05-01       Impact factor: 8.171

8.  Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.

Authors:  Kam Chuen Lai; Shiu Kum Lam; Kent Man Chu; Benjamin C Y Wong; Wai Mo Hui; Wayne H C Hu; George K K Lau; Wai Man Wong; Man Fung Yuen; Annie O O Chan; Ching Lung Lai; John Wong
Journal:  N Engl J Med       Date:  2002-06-27       Impact factor: 91.245

9.  Epidemiological study of peptic ulcer disease among Japanese and Koreans in Japan.

Authors:  Y Watanabe; J H Kurata; K Kawamoto; K Kawai
Journal:  J Clin Gastroenterol       Date:  1992-07       Impact factor: 3.062

10.  Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults.

Authors:  S Rosenstock; T Jørgensen; O Bonnevie; L Andersen
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

View more
  2 in total

1.  Association of smoking, alcohol and NSAIDs use with expression of cag A and cag T genes of Helicobacter pylori in salivary samples of asymptomatic subjects.

Authors:  Pinaki Ghosh; Subhash Laxmanrao Bodhankar
Journal:  Asian Pac J Trop Biomed       Date:  2012-06

2.  Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study.

Authors:  Anoja W Gunaratne; Harrison Hamblin; Annabel Clancy; Aleja Jane Marie C Magat; Marie Vic M Dawson; Jeffrey Tu; Thomas J Borody
Journal:  Helicobacter       Date:  2021-07-10       Impact factor: 5.753

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.